These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 11239500

  • 1. Ultrastructural morphology and localisation of cisplatin-induced platinum-DNA adducts in a cisplatin-sensitive and -resistant human small cell lung cancer cell line using electron microscopy.
    Meijera C, van Luyn MJ, Nienhuis EF, Blom N, Mulder NH, de Vries EG.
    Biochem Pharmacol; 2001 Mar 01; 61(5):573-8. PubMed ID: 11239500
    [Abstract] [Full Text] [Related]

  • 2. Immunocytochemical analysis of cisplatin-induced platinum-DNA adducts with double-fluorescence video microscopy.
    Meijer C, de Vries EG, Dam WA, Wilkinson MH, Hollema H, Hoekstra HJ, Mulder NH.
    Br J Cancer; 1997 Mar 01; 76(3):290-8. PubMed ID: 9252194
    [Abstract] [Full Text] [Related]

  • 3. The formation and removal of cisplatin (CDDP) induced DNA adducts in a CDDP sensitive and resistant human small cell lung carcinoma (HSCLC) cell line.
    Hospers GA, de Vries EG, Mulder NH.
    Br J Cancer; 1990 Jan 01; 61(1):79-82. PubMed ID: 2153398
    [Abstract] [Full Text] [Related]

  • 4. JM216-, JM118-, and cisplatin-induced cytotoxicity in relation to platinum-DNA adduct formation, glutathione levels and p53 status in human tumour cell lines with different sensitivities to cisplatin.
    Fokkema E, Groen HJ, Helder MN, de Vries EG, Meijer C.
    Biochem Pharmacol; 2002 Jun 01; 63(11):1989-96. PubMed ID: 12093475
    [Abstract] [Full Text] [Related]

  • 5. The role of glutathione in resistance to cisplatin in a human small cell lung cancer cell line.
    Meijer C, Mulder NH, Hospers GA, Uges DR, de Vries EG.
    Br J Cancer; 1990 Jul 01; 62(1):72-7. PubMed ID: 2390486
    [Abstract] [Full Text] [Related]

  • 6. Effects of gemcitabine on cis-platinum-DNA adduct formation and repair in a panel of gemcitabine and cisplatin-sensitive or -resistant human ovarian cancer cell lines.
    Peters GJ, Van Moorsel CJ, Lakerveld B, Smid K, Noordhuis P, Comijn EC, Weaver D, Willey JC, Voorn D, Van der Vijgh WJ, Pinedo HM.
    Int J Oncol; 2006 Jan 01; 28(1):237-44. PubMed ID: 16328001
    [Abstract] [Full Text] [Related]

  • 7. Correlation of the response to cisplatin of human ovarian cancer cell lines, originating from one tumor but with different sensitivity, with the recovery of DNA adducts.
    De Pooter CM, Van Oosterom AT, Scalliet PG, Maes RA, de Bruijn EA.
    Biochem Pharmacol; 1996 Mar 08; 51(5):629-34. PubMed ID: 8615899
    [Abstract] [Full Text] [Related]

  • 8. Mechanism of hyperthermic potentiation of cisplatin action in cisplatin-sensitive and -resistant tumour cells.
    Hettinga JV, Lemstra W, Meijer C, Dam WA, Uges DR, Konings AW, De Vries EG, Kampinga HH.
    Br J Cancer; 1997 Mar 08; 75(12):1735-43. PubMed ID: 9192975
    [Abstract] [Full Text] [Related]

  • 9. Role of carrier ligand in platinum resistance of human carcinoma cell lines.
    Schmidt W, Chaney SG.
    Cancer Res; 1993 Feb 15; 53(4):799-805. PubMed ID: 8428361
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A study of human small-cell lung carcinoma (hSCLC) cell lines with different sensitivities to detect relevant mechanisms of cisplatin (CDDP) resistance.
    Hospers GA, Meijer C, de Leij L, Uges DR, Mulder NH, de Vries EG.
    Int J Cancer; 1990 Jul 15; 46(1):138-44. PubMed ID: 2163989
    [Abstract] [Full Text] [Related]

  • 12. Determination of cisplatin 1,2-intrastrand guanine-guanine DNA adducts in human leukocytes by high-performance liquid chromatography coupled to inductively coupled plasma mass spectrometry.
    Harrington CF, Le Pla RC, Jones GD, Thomas AL, Farmer PB.
    Chem Res Toxicol; 2010 Aug 16; 23(8):1313-21. PubMed ID: 20666396
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Role of DNA replication in carrier-ligand-specific resistance to platinum compounds in L1210 cells.
    Gibbons GR, Kaufmann WK, Chaney SG.
    Carcinogenesis; 1991 Dec 16; 12(12):2253-7. PubMed ID: 1747924
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Gene-specific repair of Pt/DNA lesions and induction of apoptosis by the oral platinum drug JM216 in three human ovarian carcinoma cell lines sensitive and resistant to cisplatin.
    O'Neill CF, Koberle B, Masters JR, Kelland LR.
    Br J Cancer; 1999 Dec 16; 81(8):1294-303. PubMed ID: 10604725
    [Abstract] [Full Text] [Related]

  • 19. Carboplatin- and cisplatin-induced potentiation of moderate-dose radiation cytotoxicity in human lung cancer cell lines.
    Groen HJ, Sleijfer S, Meijer C, Kampinga HH, Konings AW, De Vries EG, Mulder NH.
    Br J Cancer; 1995 Dec 16; 72(6):1406-11. PubMed ID: 8519652
    [Abstract] [Full Text] [Related]

  • 20. Effect of novobiocin on cisplatin cytotoxicity and DNA interstrand cross-link formation in a cisplatin-resistant, small-cell lung carcinoma cell line.
    de Jong S, Timmer-Bosscha H, de Vries EG, Mulder NH.
    Int J Cancer; 1993 Jan 02; 53(1):110-7. PubMed ID: 8380054
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.